The Scientist

» innovation and disease/medicine

Most Recent

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Second Victim of Hantavirus

Second Victim of Hantavirus

By | August 28, 2012

Another person has died from the rodent-borne disease after visiting Yosemite National Park.

0 Comments

image: Texan West Nile Concerns

Texan West Nile Concerns

By | August 27, 2012

Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.

0 Comments

image: Blood Spots Are Epigenetic Time Capsules

Blood Spots Are Epigenetic Time Capsules

By | August 22, 2012

Researchers show that blood spotted onto Guthrie cards, usually at birth, can be a high quality source of methylated DNA for long-term epigenetic studies.

0 Comments

image: Zoo Virus Swap

Zoo Virus Swap

By | August 17, 2012

A polar bear in a German zoo dies after contracting a virus normally found in zebras.

3 Comments

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

image: HIV Drugs Go Generic

HIV Drugs Go Generic

By | August 16, 2012

Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.

1 Comment

image: Restoring Sight

Restoring Sight

By | August 13, 2012

A strategy to transmit signals to retinal nerve cells may show promise as a step toward alternative retinal prosthesis design.

0 Comments

image: Next Generation: In Vivo Drug Factories

Next Generation: In Vivo Drug Factories

By | August 13, 2012

Researchers use UV light to stimulate protein production in nano-sized delivery capsules in mice.

7 Comments

image: Pharma's Fake Innovation Crisis?

Pharma's Fake Innovation Crisis?

By | August 13, 2012

Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.

2 Comments

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. National Academies Detail the State of Weed Science
  3. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  4. Trumping Science: Part III
    The Nutshell Trumping Science: Part III

    Scientists criticize unconfirmed reports that President-elect Donald Trump has asked Robert Kennedy Jr., an anti-vaccine activist, to investigate vaccine safety.

RayBiotech